162 related articles for article (PubMed ID: 28473189)
1. A Tale of Two Cancers: Traveling to Treat Pancreatic and Thyroid Cancer.
White MG; Applewhite MK; Kaplan EL; Angelos P; Huo D; Grogan RH
J Am Coll Surg; 2017 Jul; 225(1):125-136.e6. PubMed ID: 28473189
[TBL] [Abstract][Full Text] [Related]
2. Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two different diseases receive the same treatment? A matched comparison study of the French Surgical Association (AFC).
Duconseil P; Périnel J; Autret A; Adham M; Sauvanet A; Chiche L; Mabrut JY; Tuech JJ; Mariette C; Régenet N; Fabre JM; Bachellier P; Delpéro JR; Paye F; Turrini O
Eur J Surg Oncol; 2017 Sep; 43(9):1704-1710. PubMed ID: 28687431
[TBL] [Abstract][Full Text] [Related]
3. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
4. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
[TBL] [Abstract][Full Text] [Related]
6. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
7. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers.
Lidsky ME; Sun Z; Nussbaum DP; Adam MA; Speicher PJ; Blazer DG
Ann Surg; 2017 Aug; 266(2):333-338. PubMed ID: 27429020
[TBL] [Abstract][Full Text] [Related]
8. Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes.
Xu Z; Becerra AZ; Justiniano CF; Boodry CI; Aquina CT; Swanger AA; Temple LK; Fleming FJ
Dis Colon Rectum; 2017 Dec; 60(12):1250-1259. PubMed ID: 29112560
[TBL] [Abstract][Full Text] [Related]
9. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
10. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
11. Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis.
Muller S; Senne M; Kirschniak A; Königsrainer A; Bares R; Falch C
World J Surg Oncol; 2017 Oct; 15(1):190. PubMed ID: 29065879
[TBL] [Abstract][Full Text] [Related]
12. Differentiated thyroid cancer: role of the lymph node dissection.
Caglià P; Zappulla E; Costa S; Tracia M; Veroux M; Russo V; Borzì L; Lucifora B; Patanè G; Tracia L; Amodeo C
G Chir; 2010; 31(6-7):293-5. PubMed ID: 20646374
[TBL] [Abstract][Full Text] [Related]
13. [Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers].
Szujó S; Bajnok L; Bódis B; Nemes O; Rucz K; Mezősi E
Orv Hetil; 2018 Jun; 159(22):878-884. PubMed ID: 29806478
[TBL] [Abstract][Full Text] [Related]
14. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
15. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
17. Initiation of adjuvant therapy following surgical resection of pancreatic ductal adenocarcinoma (PDAC): Are patients from rural, remote areas disadvantaged?
Bertens KA; Massman JD; Helton S; Garbus S; Mandelson MM; Lin B; Picozzi VJ; Biehl T; Alseidi AA; Rocha FG
J Surg Oncol; 2018 Jun; 117(8):1655-1663. PubMed ID: 29761510
[TBL] [Abstract][Full Text] [Related]
18. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
19. [Application of central lymph node dissection to surgical operation for clinical stage n0 papillary thyroid carcinoma].
Hu W; Shi JY; Sheng Y; Ll L
Ai Zheng; 2008 Mar; 27(3):304-6. PubMed ID: 18334122
[TBL] [Abstract][Full Text] [Related]
20. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
Shindo M; Wu JC; Park EE; Tanzella F
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):650-4. PubMed ID: 16785411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]